Idrees Mian Selected Research

LMB-100

11/2020	Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin.
1/2020	Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Idrees Mian Research Topics

Disease

5	Mesothelioma 10/2021 - 01/2019
3	Neoplasms (Cancer) 11/2020 - 01/2020
2	Malignant Mesothelioma 10/2021 - 01/2019
1	Disease Progression 10/2021
1	Lung Neoplasms (Lung Cancer) 11/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020
1	Capillary Leak Syndrome 11/2020
1	Adenocarcinoma of Lung 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Multiple Myeloma 12/2016

Drug/Important Bio-Agent (IBA)

2	MesothelinIBA 11/2020 - 01/2020
2	pembrolizumabIBA 11/2020 - 01/2020
2	LMB-100IBA 11/2020 - 01/2020
2	Immunotoxins (Immunotoxin)IBA 11/2020 - 01/2020
1	olaparibIBA 10/2021
1	Surface Antigens (Surface Antigen)IBA 11/2020
1	CreatinineIBA 11/2020
1	B7-H1 AntigenIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	NivolumabIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Blocking AntibodiesIBA 01/2020
1	AsbestosIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	PlatinumIBA 01/2019
1	Lenalidomide (CC 5013)FDA Link 12/2016

Therapy/Procedure

2	Therapeutics 11/2020 - 12/2016
1	Radiotherapy 01/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Hematopoietic Stem Cell Transplantation 12/2016